NPS Pharma says Glaxo stops osteoporosis drug study (Reuters, 25 September 2008)
GlaxoSmithKline has terminated the mid-stage study of the drug Ronacaleret in post-menopausal women with osteoporosis earlier than expected due to an observed lack of efficacy.Full article